Evidence map›Paper›PMID 42120775›Full record

ReviewHypertension research : official journal of the Japanese Society of Hypertension2026

Asian expert consensus on high-quality hypertension management.

Jing Liu, Kazuomi Kario, Xiaoqiang Ding, Zixiao Li, Tianli Gao, Yan Li, Yuqing Zhang, Wei Chen, Yook-Chin Chia, Yuhua Fan and 9 more

Abstract readConsensus StatementReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Seasonal variation in the office and ambulatory blood pressure control in patients treated with two dual antihypertensive therapies.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  2. For better blood pressure control in Asia.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Jing LiuDepartment of Hypertension, Peking University People's Hospital; Vascular Health Research Center, Peking University Health Science Center, Beijing, China.
Kazuomi KarioDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Xiaoqiang DingNephrology Department, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Zixiao LiDepartment of Neurology, Beijing Tiantan Hospital Affiliated to Capital Medical University, Beijing, China.
Tianli GaoDepartment of Cerebrovascular Disease, Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing, China.
Yan LiDepartment of Cardiovascular Medicine, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Yuqing ZhangDivisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wei ChenDepartment of Nephrology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Yook-Chin ChiaDepartment of Clinical Medicine and Surgery Sir Jeffrey Cheah Sunway Medical School, Faculty of Medical and Life Sciences, Sunway University, Bandar Sunway, Selangor, Malaysia; Department of Primary Care Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia; Ageing, Health and Wellbeing Research Centre (CARE), Faculty of Medical and Life Sciences, Sunway University, Bandar Sunway, Selangor, Malaysia.
Yuhua FanDepartment of Neurology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Satoshi HoshideDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Huijuan MaoDepartment of Nephrology, Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University), Nanjing, China.
Jinho ShinFaculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea.
Apichard SukonthasarnDepartment of Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Boon Wee TeoDivision of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Yuda TuranaDepartment of Neurology. School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.
Li YaoDepartment of Nephrology, The First Affiliated Hospital of China Medical University, Shenyang, China.
Hong ZhangRenal Division, Peking University First Hospital, Beijing, China.
Ji-Guang WangDepartment of Hypertension, Centre for Epidemiological Studies and Clinical Trials, the Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. jiguangwang@rjh.com.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-quality hypertension management is a new concept proposed to improve blood pressure (BP) control in Asia. Out-of-office BP measurements, including ambulatory and home BP monitoring, and wearable BP measurement, are recommended for BP assessment. Long-acting antihypertensive agents at full dose or in combination are priority strategies for achieving 24-h (24-h) BP control, reducing blood pressure variability (BPV) and improving time-in-target range (TTR). High-quality hypertension management across multiple disciplines will be a pragmatic strategy for the reduction in the risk of cardio-cerebrovascular and renal complications and mortality among Asian hypertensive patients.

Indexed as

Antihypertensive AgentsHypertensionAsiaBlood PressureBlood Pressure DeterminationBlood Pressure Monitoring, AmbulatoryHumansAntihypertensive Agents24-h blood pressure controlHigh-quality hypertension managementImplemention hypertensionLong term blood pressure managementTime-in-target range

Identifiers

PMID42120775
PMCPMC13333500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.